336 related articles for article (PubMed ID: 29667859)
1. Prescribing naloxone for opioid overdose intervention.
Dunne RB
Pain Manag; 2018 May; 8(3):197-208. PubMed ID: 29667859
[TBL] [Abstract][Full Text] [Related]
2. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.
Mueller SR; Walley AY; Calcaterra SL; Glanz JM; Binswanger IA
Subst Abus; 2015; 36(2):240-53. PubMed ID: 25774771
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review.
Ryan SA; Dunne RB
Pain Manag; 2018 May; 8(3):231-245. PubMed ID: 29683378
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
[TBL] [Abstract][Full Text] [Related]
6. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
[TBL] [Abstract][Full Text] [Related]
7. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.
Beletsky L; Ruthazer R; Macalino GE; Rich JD; Tan L; Burris S
J Urban Health; 2007 Jan; 84(1):126-36. PubMed ID: 17146712
[TBL] [Abstract][Full Text] [Related]
8. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
9. Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal.
Strang J; McDonald R; Alqurshi A; Royall P; Taylor D; Forbes B
Drug Alcohol Depend; 2016 Jun; 163():16-23. PubMed ID: 26996745
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an Opiate Overdose Educational Intervention and Naloxone Prescribing Program in Homeless Adults Who Use Opiates.
Pietrusza LM; Puskar KR; Ren D; Mitchell AM
J Addict Nurs; 2018; 29(3):188-195. PubMed ID: 30180005
[TBL] [Abstract][Full Text] [Related]
11. An opioid overdose curriculum for medical residents: Impact on naloxone prescribing, knowledge, and attitudes.
Taylor JL; Rapoport AB; Rowley CF; Mukamal KJ; Stead W
Subst Abus; 2018; 39(3):371-376. PubMed ID: 29432074
[TBL] [Abstract][Full Text] [Related]
12. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
13. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
[TBL] [Abstract][Full Text] [Related]
14. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
[TBL] [Abstract][Full Text] [Related]
15. Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center.
Zschoche JH; Nesbit S; Murtaza U; Sowell A; Waldfogel JM; Arwood N; Rush J; McNamara L; Swarthout M; Nesbit T; Ortmann M
Am J Health Syst Pharm; 2018 Nov; 75(22):1812-1820. PubMed ID: 30076167
[TBL] [Abstract][Full Text] [Related]
16. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
Klimas J; Egan M; Tobin H; Coleman N; Bury G
BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
[TBL] [Abstract][Full Text] [Related]
17. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
[TBL] [Abstract][Full Text] [Related]
18. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
Maxwell S; Bigg D; Stanczykiewicz K; Carlberg-Racich S
J Addict Dis; 2006; 25(3):89-96. PubMed ID: 16956873
[TBL] [Abstract][Full Text] [Related]
19. Management of Suspected Opioid Overdose With Naloxone in Out-of-Hospital Settings: A Systematic Review.
Chou R; Korthuis PT; McCarty D; Coffin PO; Griffin JC; Davis-O'Reilly C; Grusing S; Daya M
Ann Intern Med; 2017 Dec; 167(12):867-875. PubMed ID: 29181532
[TBL] [Abstract][Full Text] [Related]
20. The Rhode Island community responds to opioid overdose deaths.
Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
